CHRISTYANN LYNCH: Open Payments
NPI 1366762460 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 28 payments from 11 companies in 2025. Trend: 2023 $260 · 2024 $318 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 10 | $338 |
| Ferring Pharmaceuticals Inc. | 7 | $169 |
| Procept Biorobotics Corporation | 1 | $126 |
| Smith+Nephew, Inc. | 3 | $83 |
| Solventum Corporation | 1 | $61 |
| UROGEN PHARMA, INC. | 1 | $36 |
| Janssen Biotech, Inc. | 1 | $34 |
| Blue Earth Diagnostics | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| ABBVIE INC. | 1 | $26 |
Products named: GEMTESA, ADSTILADRIN, AQUABEAM ROBOTIC SYSTEM, PICO, ACTIV.A.C., ERLEADA, POSLUMA, KEYTRUDA.
Industry payments across NY — which companies pay providers there.
